ClinicalTrials.Veeva

Menu

Diagnosis of Superficial Lymphadenopathy

Zhejiang University logo

Zhejiang University

Status

Unknown

Conditions

ULTRASOUND
Lymphadenopathy

Treatments

Diagnostic Test: SMI

Study type

Observational

Funder types

Other

Identifiers

NCT04928560
2020-588

Details and patient eligibility

About

The purpose of this study is to study the application of CEUS and SMI technology in superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Full description

CEUS and SMI technology were used to evaluated the superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 18 years old and ≤ 80 years old;
  2. Patients with enlarged lymph nodes detected by ultrasound;
  3. No contraindications such as hypersensitivity to contrast-enhanced ultrasound;
  4. Voluntarily enrolled in this research project

Exclusion criteria

  • The patient's position cannot be matched during ultrasound examination

    • Treatment history of lesion area: operation, radiotherapy, intervention, etc ③ Patients without informed consent ④ Lack of clinical data (no effective images such as two-dimensional ultrasound, color Doppler, contrast-enhanced ultrasound, micro blood flow imaging, or poor image quality, unable to analyze, unknown pathological results, etc.) ⑤ Lack of follow up information

Trial design

500 participants in 2 patient groups

disease free survival
Description:
disease free survival
Treatment:
Diagnostic Test: SMI
non-disease free survival
Description:
non-disease free survival
Treatment:
Diagnostic Test: SMI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems